Cargando…
Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled Trial of Metformin for Antipsychotic-Induced Weight Gain in Patients with First-Episode Psychosis: A Pilot Study
Excessive weight gain and cardiometabolic dysfunction are common and clinically relevant side effects of antipsychotic medications. In this pilot study, we aimed to establish the feasibility of using metformin and its effectiveness in managing antipsychotic-induced weight gain in patients with first...
Autores principales: | Tang, Charmaine, Chua, Yi Chian, Abdin, Edimansyah, Subramaniam, Mythily, Verma, Swapna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750805/ https://www.ncbi.nlm.nih.gov/pubmed/35010394 http://dx.doi.org/10.3390/ijerph19010137 |
Ejemplares similares
-
A retrospective database study on 2-year weight trajectories in first-episode psychosis
por: Chua, Yi Chian, et al.
Publicado: (2023) -
Growth in the Aftermath of Psychosis: Characterizing Post-traumatic Growth in Persons With First Episode Psychosis in Singapore
por: Lee, Ying Ying, et al.
Publicado: (2022) -
Autistic traits in first‐episode psychosis: Rates and association with 1‐year recovery outcomes
por: Zheng, Shushan, et al.
Publicado: (2020) -
Effectiveness of Paliperidone Palmitate in Reducing Acute Psychiatric Service Use for Patients Suffering from Psychosis—A Retrospective Mirror-Image Study
por: Chan, Chun Ting, et al.
Publicado: (2023) -
Quality of Life and Its Associations with Religiosity and Religious Coping among Outpatients with Psychosis in Singapore
por: Roystonn, Kumarasan, et al.
Publicado: (2021)